Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice
PLoS ONE, ISSN: 1932-6203, Vol: 5, Issue: 9, Page: 1-9
2010
- 11Citations
- 22Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- 11
- CrossRef9
- Captures22
- Readers22
- 22
- Mentions1
- News Mentions1
- 1
Most Recent News
Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics
Introduction Telomere is a protective structure located at the end of the linear chromosome of eukaryotes, which is made up of tandem repetitive DNA sequences
Article Description
Background: hTERTC27 is a 27 kDa C-terminal polypeptide of human telomerase reverse transcriptase that has previously been shown to reduce tumorigenicity of HeLa cells and suppress growth of xenografted glioblastoma in nude mice. Although ectopic expression of hTERTC27 upregulated genes that are involved in apoptosis, cell cycle, and immune response, the mechanism for hTERTC27-induced tumor suppression has not been completely elucidated. Since hTERT was identified as a universal tumor-associated antigen, we hypothesize that hTERTC27 inhibits tumor growth in vivo through activation of anti-tumor immune response. Methodology/Principal Finding: Immunocopetent C57BL/6 mice were used for mouse B16 melanoma model. Mice bearing B16 melanoma were administered rAAV-/rAdv viral cocktail expressing hTERTC27, and tumor growth was monitored after viral cocktail treatment. Blood and splenocytes were used to determine the level of cytokines and the activity of immune cells, respectively. B16 tumor growth was significantly inhibited by subcutaneous administration of a single dose of 1.5×10 vg rAAV-hTERTC27 and 2.5×10 pfu rAdv-hTERTC27 viral cocktail (rAAV-/rAdv-hTERTC27). The population and cytotoxicity of NK cells in the mice were significantly augmented by rAAV-/rAdv-hTERTC27 treatment, and selective depletion of the NK cell population in mice by intraperitoneal injection of anti-GM1 antibody abrogated the growth suppression of melanoma induced by rAAV-/rAdv-hTERTC27 administration. Conclusion: Activation of NK cells by administration of rAAV-/rAdv-hTERTC27 is critical for growth suppression of melanoma in mouse model. © 2010 Huo et al.
Bibliographic Details
10.1371/journal.pone.0012705; 10.1371/journal.pone.0012705.g004; 10.1371/journal.pone.0012705.g001; 10.1371/journal.pone.0012705.g005; 10.1371/journal.pone.0012705.g003; 10.1371/journal.pone.0012705.g002
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77958583393&origin=inward; http://dx.doi.org/10.1371/journal.pone.0012705; http://www.ncbi.nlm.nih.gov/pubmed/20856939; https://dx.plos.org/10.1371/journal.pone.0012705.g004; http://dx.doi.org/10.1371/journal.pone.0012705.g004; https://dx.plos.org/10.1371/journal.pone.0012705.g001; http://dx.doi.org/10.1371/journal.pone.0012705.g001; https://dx.plos.org/10.1371/journal.pone.0012705.g005; http://dx.doi.org/10.1371/journal.pone.0012705.g005; https://dx.plos.org/10.1371/journal.pone.0012705.g003; http://dx.doi.org/10.1371/journal.pone.0012705.g003; https://dx.plos.org/10.1371/journal.pone.0012705; https://dx.plos.org/10.1371/journal.pone.0012705.g002; http://dx.doi.org/10.1371/journal.pone.0012705.g002; https://dx.doi.org/10.1371/journal.pone.0012705.g004; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0012705.g004; https://dx.doi.org/10.1371/journal.pone.0012705; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012705; https://dx.doi.org/10.1371/journal.pone.0012705.g003; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0012705.g003; https://dx.doi.org/10.1371/journal.pone.0012705.g002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0012705.g002; https://dx.doi.org/10.1371/journal.pone.0012705.g005; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0012705.g005; https://dx.doi.org/10.1371/journal.pone.0012705.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0012705.g001; http://dx.plos.org/10.1371/journal.pone.0012705.g003; http://dx.plos.org/10.1371/journal.pone.0012705.g004; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012705; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0012705&type=printable; http://dx.plos.org/10.1371/journal.pone.0012705.g001; http://dx.plos.org/10.1371/journal.pone.0012705.g005; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0012705; http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0012705&type=printable; http://dx.plos.org/10.1371/journal.pone.0012705; http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0012705; http://dx.plos.org/10.1371/journal.pone.0012705.g002
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know